South Korea to India: Syringe Import Trade Route
India has recorded 30 verified shipments of Syringe imported from South Korea, representing a combined trade value of $51.6K USD. This corridor is served by 5 active South Korea exporters, with an average shipment value of $1.7K USD. The leading South Korea supplier is SPIDENT CO LIMITED, which accounts for 55% of total import value with 21 shipments worth $28.2K USD. On the buying side, IDS DENMED PRIVATE LIMITED is the largest Indian importer with $28.2K USD in purchases. The top 3 suppliers — SPIDENT CO LIMITED, META BIOMED CO LTD, ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE LTD — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The South Korea to India Syringe corridor is one of India's established pharmaceutical import routes from South Korea, with 30 shipments documented worth a combined $51.6K USD. The route is dominated by SPIDENT CO LIMITED, which alone accounts for roughly 55% of all import value, reflecting the consolidated nature of South Korea's syringe export sector.
Across 5 active South Korea suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with syringe's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #19 among India's top syringe import origins globally.
On the Indian buyer side, key Indian importers include IDS DENMED PRIVATE LIMITED, CONFIDENT SALES INDIA PVT LTD, DR.REDDY'S LABORATORIES LTD and 2 others. IDS DENMED PRIVATE LIMITED is the single largest Indian importer with 21 shipments valued at $28.2K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ4
- Primary modeSea freight
- Top port of entryDELHI AIR
Market Position
- Global rank#19
- Annual growth+29.2%
- Demand growth+24.4%
- Regulatory ease74/100
Top 10 Syringe Exporters from South Korea to India
Showing top 10 of 5 South Korea suppliers exporting Syringe to India, ranked by total trade value (USD)
| Rank | Supplier (South Korea Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SPIDENT CO LIMITED Avg $1.3K per shipment | 21 | $28.2K | 54.7% |
| 2 | META BIOMED CO LTD Avg $5.4K per shipment | 3 | $16.3K | 31.5% |
| 3 | ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE LTD Avg $5.6K per shipment | 1 | $5.6K | 10.8% |
| 4 | META BIOMED CO,LTD Avg $1.0K per shipment | 1 | $1.0K | 2.0% |
| 5 | NOBEL BIOCARE SERVICES AG Avg $125 per shipment | 4 | $501 | 1.0% |
This table shows the top 10 of 5 South Korea companies exporting syringe to India, ranked by total trade value. The listed exporters are: SPIDENT CO LIMITED, META BIOMED CO LTD, ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE LTD, META BIOMED CO,LTD, NOBEL BIOCARE SERVICES AG. SPIDENT CO LIMITED is the dominant supplier with 21 shipments worth $28.2K USD, giving it a 55% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Indian Syringe Importers from South Korea
Showing top 10 of 5 known Indian buyers receiving Syringe shipments from South Korea, ranked by import value
On the receiving end of this trade route, the leading Indian importers of South Korea syringe include IDS DENMED PRIVATE LIMITED, CONFIDENT SALES INDIA PVT LTD, DR.REDDY'S LABORATORIES LTD, UNION-DENTAL PRIVATE LIMITED, NOBEL BIOCARE INDIA PRIVATE LIMITED. The largest importer is IDS DENMED PRIVATE LIMITED, accounting for $28.2K USD across 21 shipments — representing 55% of all syringe imports from South Korea on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IDS DENMED PRIVATE LIMITED | 21 | $28.2K | 54.7% |
| 2 | CONFIDENT SALES INDIA PVT LTD | 3 | $16.3K | 31.5% |
| 3 | DR.REDDY'S LABORATORIES LTD | 1 | $5.6K | 10.8% |
| 4 | UNION-DENTAL PRIVATE LIMITED | 1 | $1.0K | 2.0% |
| 5 | NOBEL BIOCARE INDIA PRIVATE LIMITED | 4 | $501 | 1.0% |
Top 10 Syringe Formulations Imported from South Korea
Showing top 10 of 28 product formulations shipped on the South Korea to India Syringe route, ranked by trade value
India imports a wide range of syringe formulations from South Korea, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ESCOM250 SYSTEM KIT A1:1 A2:2 A31 B2:14G X 5 SYRINGESDENTAL FILLING — accounts for $17.2K USD across 1 shipments. There are 28 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ESCOM250 SYSTEM KIT A1:1 A2:2 A31 B2:14G X 5 SYRINGESDENTAL FILLING | 1 | $17.2K | 33.3% |
| 2 | DENTAL FILLINGS METAPEX 2SYRINGE 20TIPS 112 KGS 1400 BOX | 1 | $15.2K | 29.5% |
| 3 | ORENCIA (ABATECEPT) PREFILLED SYRINGE 125MG(OREINJ02KR) ORENCIA (ABATECEPT) PREFILLED SYRINGE 125MG(OREINJ02KR) | 1 | $5.6K | 10.8% |
| 4 | ESFLOW A2 2G X 2 SYRINGES DENTAL FILLING | 1 | $3.6K | 6.9% |
| 5 | META ETCHANT 3SYRINGES (DENTAL HYGIENE PRERPARATION) . | 1 | $1.0K | 2.0% |
| 6 | ESFLOW A2 LEAFLET 2G X 1 SYRINGES DENTAL FILLINGFREE OFCHARGE | 1 | $963 | 1.9% |
| 7 | ESCEM A2 8G X 1 SYRINGES DENTAL FILLING | 1 | $891 | 1.7% |
| 8 | ESCOM100 SYSTEM KIT A1:1 A2:2 A31 B2:14G X 5 SYRINGESDENTAL FILLING | 1 | $888 | 1.7% |
| 9 | ESFLOW A3 2G X 2 SYRINGES DENTAL FILLING | 1 | $874 | 1.7% |
| 10 | ESFLOW A1 2G X 2 SYRINGES DENTAL FILLING | 1 | $874 | 1.7% |
Showing top 10 of 28 Syringe formulations imported from South Korea on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
DELHI AIR handles the highest volume with 21 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's syringe imports from South Korea are driven primarily by a handful of large-scale South Korea manufacturers. SPIDENT CO LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — Indian buyers benefit from South Korea supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SPIDENT CO LIMITED, META BIOMED CO LTD, ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE LTD — together account for 97% of total trade value on this route. The average shipment value of $1.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as dental fillings metapex 2syringe 20tips 112 kgs 1400 box and orencia (abatecept) prefilled syringe 125mg(oreinj02kr) orencia (abatecept) prefilled syringe 125mg(oreinj02kr), suggesting that Indian buyers tend to consolidate orders across related product lines from the same South Korea supplier.
On the buying side, IDS DENMED PRIVATE LIMITED is the largest importer with 21 shipments worth $28.2K USD — representing 55% of all syringe imports from South Korea on this route.
Route Statistics
- Trade Volume
- $51.6K
- Avg. Shipment
- $1.7K
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~31 days
- Annual Growth
- +29.2%
Unlock the Full South Korea to India Syringe Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 30 shipments on this route.
Frequently Asked Questions — South Korea to India Syringe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which South Korea companies export Syringe to India?
The leading South Korea exporters of Syringe to India are SPIDENT CO LIMITED, META BIOMED CO LTD, ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE LTD. SPIDENT CO LIMITED holds the largest market share at approximately 55% of total trade value on this route.
Q What is the total value of Syringe imports from South Korea to India?
India imports Syringe from South Korea worth approximately $51.6K USD across 30 recorded shipments. The average value per shipment is $1.7K USD.
Q Which Indian ports receive Syringe from South Korea?
The most active Indian port of entry is DELHI AIR with 21 shipments. South Korea exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from South Korea to India for Syringe?
The average transit time for Syringe shipments from South Korea to India is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the South Korea to India Syringe import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.2% with demand growth tracking at 24.4%. The route is ranked #19 among India's top Syringe import origins globally.
Q How many South Korea suppliers are active on this Syringe import route?
There are currently 5 active South Korea suppliers exporting Syringe to India. The market is moderately concentrated with SPIDENT CO LIMITED accounting for 55% of total shipment value.
Q Who are the main Indian importers of Syringe from South Korea?
The leading Indian importers of Syringe from South Korea include IDS DENMED PRIVATE LIMITED, CONFIDENT SALES INDIA PVT LTD, DR.REDDY'S LABORATORIES LTD, UNION-DENTAL PRIVATE LIMITED, NOBEL BIOCARE INDIA PRIVATE LIMITED. IDS DENMED PRIVATE LIMITED is the largest buyer with 21 shipments worth $28.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to South Korea export trade corridor identified from Indian Customs (DGFT) records for Syringe.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in South Korea matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 30 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists